WHO ICTRP trial
Retrospective clinical observation for anlotinib hydrochloride in the treatment…
ChiCTR1900020766 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR1900020766 |
|---|---|
| Public title | Retrospective clinical observation for anlotinib hydrochloride in the treatment of retinal ovarian cancer |
| Scientific title | Retrospective clinical observation for anlotinib hydrochloride in the treatment of retinal ovarian cancer |
| Primary sponsor | Sir Run Run Shaw Hospital Zhejiang University,School of Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | Retrospective study |
| Conditions | ovarian cancer |
| Interventions | Case series:anlotinib |
| Registration date | Jan 19, 2019 |
| Target size | Case series:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: